日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clock gene ARNTL2 enhances 5-fluorouracil resistance in colon cancer by upregulating SLC7A11 to suppress ferroptosis.

时钟基因 ARNTL2 通过上调 SLC7A11 抑制铁死亡,从而增强结肠癌对 5-氟尿嘧啶的耐药性

Yang Jingbang, Lin Dagui, Huang Yulin, Yin Shasha, Chen Miao, Sun Haohui, Zhu Wancui, Chen Enni, Deng Yizhang, Zhao Enen, Wang Fulong, Zhang Linjie, Deng Wuguo, Li Liren

Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I-IV colorectal cancer

循环肿瘤DNA分析可预测I-IV期结直肠癌的复发,并避免不必要的辅助化疗。

Fan, Wenhua; Xia, Zhiyuan; Chen, Rongrong; Lin, Dagui; Li, Fang; Zheng, Yang; Luo, Jiongyong; Xiong, Yuanyuan; Yu, Pengli; Gao, Wei; Gong, Yuhua; Zhang, Feiran; Zhang, Sen; Li, Liren

Identification and validation of a novel stress granules-related prognostic model in colorectal cancer.

识别和验证一种与应激颗粒相关的新型结直肠癌预后模型

Liu Zhihao, Zhao Enen, Li Huali, Lin Dagui, Huang Chengmei, Zhou Yi, Zhang Yaxin, Pan Xingyan, Liao Wenting, Li Fengtian

Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study

转移性乳腺癌患者化疗或内分泌治疗维持治疗的临床证据:随机临床试验的荟萃分析和多中心队列研究的倾向评分匹配

Ren, Wei; Yu, Yunfang; Hong, Huangming; Wang, Ying; Gao, Quanlong; Chen, Yongjian; Chen, Peixian; Zhao, Jianli; Ou, Qiyun; Lin, Dagui; Fu, Tuping; Tan, Yujie; Li, Chenchen; Xie, Xinxin; Ye, Guolin; Tang, Jun; Yao, Herui

Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer

基于代谢相关基因表达特征的结直肠癌分子亚型鉴定和预后分层

Lin, Dagui; Fan, Wenhua; Zhang, Rongxin; Zhao, Enen; Li, Pansong; Zhou, Wenhao; Peng, Jianhong; Li, Liren

Novel blood-based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non-small-cell lung cancer: Results from two multicenter, randomized clinical trials

新型基于血液的肿瘤突变算法和列线图可预测非小细胞肺癌患者接受免疫检查点抑制剂治疗后的生存期:来自两项多中心随机临床试验的结果

Yu, Yunfang; Chen, Yongjian; Li, Anlin; Ou, Qiyun; Li, Qingjian; Gu, Yang; Lin, Dagui; Zhang, Wenda; Wang, Jingshu; Tang, Xudong; Li, Zhihua; Hu, Hai; Yao, Herui

Joint association of patients' sex and PD-L1 expression with overall survival benefits and tumor-immune microenvironment in immune checkpoint inhibitors for cancers

患者性别和PD-L1表达与癌症免疫检查点抑制剂治疗中总生存获益和肿瘤免疫微环境的联合关联

Li, Anlin; Chen, Yongjian; Zhang, Wenda; Zhong, Haitao; Ou, Qiyun; Gu, Yang; Xia, Junqing; Lin, Dagui; Fu, Tuping; Liu, Ruixin; Hu, Hai; Yu, Yunfang; Yao, Herui

Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation

免疫检查点抑制剂与携带蛋白酪氨酸磷酸酶受体T突变的癌症患者生存率相关

He, Zifan; Li, Anlin; Lin, Dagui; Gu, Yang; Chen, Yongjian; Ou, Qiyun; Li, Liren; Yao, Herui; Yu, Yunfang

Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma

肝细胞癌患者生存率和基因组突变特征与免疫治疗的相关性

Ou, Qiyun; Yu, Yunfang; Li, Anlin; Chen, Jie; Yu, Tingting; Xu, Xiaolin; Xie, Xinxin; Chen, Yongjian; Lin, Dagui; Zeng, Qiaohong; Zhang, Yuxin; Tang, Xudong; Yao, Herui; Luo, Baoming

Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis

非小细胞肺癌患者生存率及免疫相关生物标志物与免疫治疗的关联性:一项荟萃分析和个体患者水平分析

Yu, Yunfang; Zeng, Dongqiang; Ou, Qiyun; Liu, Shengbo; Li, Anlin; Chen, Yongjian; Lin, Dagui; Gao, Quanlong; Zhou, Haiyu; Liao, Wangjun; Yao, Herui